Chelerythrine
FAK inhibitor 5
Caplacizumab
Veltuzumab
Abrilumab
Abituzumab
RGD-4C
Efalizumab
Fasudil hydrochloride semihydrate
Etrolizumab
Volociximab
Enlimomab
Etaracizumab
Tadocizumab
Bersanlimab
Ontamalimab
Rovelizumab
ROCK-IN-6
CCG-232964
Cyclo(Ala-Arg-Gly-Asp-Mamb)